Glutamate binding is altered in hippocampus and cortex of Wistar rats after pilocarpine-induced Status Epilepticus

Neuroscience Letters

Volumn 424, Issue 1, 2007, Pages 51-54

  Cunha, Alexandra Olimpio Siqueira ^a   Mortari, Márcia Renata ^a   Carolino, Ruither Oliveira Gomes ^a   Coutinho Netto, Joaquim ^a   dos Santos, Wagner Ferreira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Binding; Glutamate; Hippocampus and cortex; Pilocarpine; Status Epilepticus

Indexed keywords

GLUTAMATE RECEPTOR; GLUTAMIC ACID; PILOCARPINE; THIOPENTAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; CONTROLLED STUDY; EPILEPTIC STATE; EPILEPTOGENESIS; HIPPOCAMPUS; LIGAND BINDING; LIMBIC SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; WISTAR RAT;

ANIMALS; BINDING SITES; CEREBRAL CORTEX; CONVULSANTS; EPILEPSY; GLUTAMIC ACID; HIPPOCAMPUS; LIGANDS; MALE; NEURONAL PLASTICITY; PILOCARPINE; RATS; RATS, WISTAR; RECEPTORS, GLUTAMATE; STATUS EPILEPTICUS; SYNAPTIC TRANSMISSION;

EID: 34548119556     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.07.010     Document Type: Article

References (25)

1. Cavazos J.E., Das I., and Sutula T.P. Neuronal loss induced in limbic pathways by kindling: evidence for induction of hippocampal sclerosis by repeated brief seizures. J. Neurosci. 14 (1994) 3106-3121
2. De Deyn P.P., D'Hooge R., Marescau B., and Pei Y.Q. Chemical models of epilepsy with some reference to their applicability in the development of anticonvulsants. Epilepsy Res. 12 (1992) 87-110
3. Ebert U., Brandt C., and Loscher W. Delayed sclerosis, neuroprotection, and limbic epileptogenesis after status epilepticus in the rat. Epilepsia 43 Suppl. 5 (2002) 86-95
4. Freitas R.M., Sousa F.C., Vasconcelos S.M., Viana G.S., and Fonteles M.M. Pilocarpine-induced status epilepticus in rats: lipid peroxidation level, nitrite formation, GABAergic and glutamatergic receptor alterations in the hippocampus, striatum and frontal cortex. Pharmacol. Biochem. Behav. 78 (2004) 327-332
5. Furtado M.d.A., Braga G.K., Oliveira J.A., Del Vecchio F., and Garcia-Cairasco N. Behavioral, morphologic, and electroencephalographic evaluation of seizures induced by intrahippocampal microinjection of pilocarpine. Epilepsia 43 Suppl. 5 (2002) 37-39
6. Hartree E.F. Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal. Biochem. 48 (1972) 422-427
7. Lason W., Turchan J., Przewlocka B., Labuz D., and Przewlocki R. Effects of repeated MK-801 administration on the glutamate receptor gene expression in the rat hippocampus. Pol. J. Pharmacol. 49 (1997) 249-253
8. Longo B.M., and Mello L.E. Blockade of pilocarpine- or kainate-induced mossy fiber sprouting by cycloheximide does not prevent subsequent epileptogenesis in rats. Neurosci. Lett. 226 (1997) 163-166
9. Loscher W. Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy. Prog. Neurobiol. 54 (1998) 721-741
10. Loscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res. 50 (2002) 105-123
11. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
12. Mathern G.W., Pretorius J.K., Mendoza D., Lozada A., and Kornblum H.I. Hippocampal AMPA and NMDA mRNA levels correlate with aberrant fascia dentata mossy fiber sprouting in the pilocarpine model of spontaneous limbic epilepsy. J. Neurosci. Res. 54 (1998) 734-753
13. Mazarati A.M., Baldwin R.A., Sankar R., and Wasterlain C.G. Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Res. 814 (1998) 179-185
14. Mello L.E., Cavalheiro E.A., Tan A.M., Kupfer W.R., Pretorius J.K., Babb T.L., and Finch D.M. Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia 34 (1993) 985-995
15. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. second ed. (1986), Academic Press, Inc., Sidney nr de pp.
16. Pitkanen A., and Kubova H. Antiepileptic drugs in neuroprotection. Expert Opin. Pharmacother. 5 (2004) 777-798
17. Racine R.J. Modification of seizure activity by electrical stimulation: II, motor seizure. Electroencephalogr. Clin. Neurophysiol. 32 (1972) 281-293
18. Rice A.C., and DeLorenzo R.J. NMDA receptor activation during status epilepticus is required for the development of epilepsy. Brain Res. 782 (1998) 240-247
19. Rigoulot M.A., Koning E., Ferrandon A., and Nehlig A. Neuroprotective properties of topiramate in the lithium-pilocarpine model of epilepsy. J. Pharmacol. Exp. Ther. 308 (2004) 787-795
20. Scimemi A., Schorge S., Kullmann D.M., and Walker M.C. Epileptogenesis is associated with enhanced glutamatergic transmission in the perforant path. J. Neurophysiol. 95 (2006) 1213-1220
21. Sloviter R.S. Permanently altered hippocampal structure, excitability, and inhibition after experimental status epilepticus in the rat: the "dormant basket cell" hypothesis and its possible relevance to temporal lobe epilepsy. Hippocampus 1 (1991) 41-66
22. Tang F.R., Chia S.C., Zhang S., Chen P.M., Gao H., Liu C.P., Khanna S., and Lee W.L. Glutamate receptor 1-immunopositive neurons in the gliotic CA1 area of the mouse hippocampus after pilocarpine-induced status epilepticus. Eur. J. Neurosci. 21 (2005) 2361-2374
23. Thom M., Zhou J., Martinian L., and Sisodiya S. Quantitative post-mortem study of the hippocampus in chronic epilepsy: seizures do not inevitably cause neuronal loss. Brain 128 (2005) 1344-1357
24. Walker M.C., White H.S., and Sander J.W. Disease modification in partial epilepsy. Brain 125 (2002) 1937-1950
25. Zukin S.R., Young A.B., and Snyder S.H. Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system. Proc. Natl. Acad. Sci. U.S.A. 71 (1974) 4802-4807